In contrast, another study reported that CD8+ T cells from patients with COVID-19 exert higher effector functions, including the production of IL-2 and IL-17A and the expression of the degranulation marker CD107a, upon anti-CD3/CD28 stimulation compared to cells from healthy donors [25]. Here, CD8A is linked to COVID-19.